References
- Gallamini A, Fiore F, Sorasio R, Meignan M. Interim positron emission tomography scan in Hodgkin lymphoma: definitions, interpretation rules, and clinical validation. Leuk Lymphoma 2009;50:1761–1764.
- Hutchings M, Barrington SF. PET/CT for therapy response assessment in lymphoma. J Nucl Med 2009;50:21S–30S.
- Juweid ME, Stroobants S, Hoekstra OS, et al Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007;25:571–578.
- Meignan M, Gallamini A, Haioun C. Report on the first international workshop on interim-PET scan in lymphoma. Leuk Lymphoma 2009;50:1257–1260.
- Kobe C, Dietlein M, Mauz-Körholz C, et al FDG-PET in Hodgkin lymphoma. Nuklearmedizin 2008;47:235–238.
- Picardi M, De Renzo A, Pane F, et al Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tompgraphy scans. Leuk Lymphoma 2007;48:1721–1727.
- Hutchings M, Loft A, Hansen M, et al FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma. Blood 2006;107:52–59.
- Markova J, Kobe C, Skopalova M, et al FDG-PET for assessment of early treatment response after 4 cycles of chemotherapy in patients with advanced-stage Hodgkin lymphoma has a high negative predictive value. Ann Oncol 2009;20:1270–1274.
- Jacene HA, Leboulleux S, Baba S, et al Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy. J Nucl Med 2009;50:1760–1769.